封面
市場調查報告書
商品編碼
2105842

全球慢性創傷護理市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Chronic Wound Care Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球慢性創傷護理市場預計將從2025年的177.4億美元成長至2034年的262億美元,2026年至2034年的複合年成長率(CAGR)為4.43%。全球慢性創傷護理市場正經歷強勁成長,這主要歸因於糖尿病潰瘍、壓瘡和靜脈性腿部潰瘍等慢性傷口盛行率的不斷上升。這些傷口需要專業的護理和先進的治療方案來促進癒合和預防併發症。糖尿病盛行率的上升和人口老化是推動慢性創傷護理產品需求成長的主要因素。

創傷護理技術的進步正在顯著改變傷口的治療方式。諸如先進敷料、負壓傷口治療系統和生物力學工程皮膚替代品等創新產品,正在改善癒合效果並縮短復原時間。醫療專業人員正擴大採用最新的創傷護理解決方案,以更有效地管理複雜傷口。

受傷口管理研究不斷深入和醫療基礎設施投資增加的推動,全球慢性創傷護理市場預計未來將持續成長。各公司正致力於開發更有效率、更經濟的創傷護理產品,以滿足日益成長的市場需求。隨著人們對慢性傷口管理的認知不斷提高,以及醫療系統對先進治療方案的重視,預計該市場將穩步擴張。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球慢性創傷護理市場:按類型分類

  • 市場分析、洞察與預測
  • 糖尿病潰瘍
  • 壓瘡
  • 下肢靜脈潰瘍
  • 其他

第5章 全球慢性創傷護理市場:依產品分類

  • 市場分析、洞察與預測
  • 進階傷口敷料
  • 用於創傷護理的醫療設備
  • 主動治療
  • 其他

第6章 全球慢性創傷護理市場:依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院和傷口診所
  • 居家照護環境及其他

第7章 全球慢性創傷護理市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • 3M Company
    • AdvaCare Pharma
    • B. Braun Melsungen AG
    • Baxter International Inc
    • Cardinal HealthInc
    • Coloplast Corp
    • ConvaTec Group Plc
    • Essity AB(BSN Medical)
    • Integra LifeSciences Corporation(Derma Sciences)
    • Johnson & Johnson
    • Medline IndustriesInc
    • MiMedx GroupInc
    • Molnlycke Health Care AB
    • PAUL HARTMANN AG
    • Smith & Nephew Plc
    • Tissue Regenix Group Plc
簡介目錄
Product Code: VMR112115301

The global chronic wound care market size is expected to reach USD 26.20 Billion in 2034 from USD 17.74 Billion in 2025, growing at a CAGR of 4.43 during 2026-2034.The Global Chronic Wound Care Market is witnessing strong growth due to the increasing prevalence of chronic wounds such as diabetic ulcers, pressure ulcers, and venous leg ulcers. These wounds require specialized care and advanced treatment solutions to promote healing and prevent complications. The rising incidence of diabetes and aging populations worldwide are major factors contributing to the growing demand for chronic wound care products.

Advancements in wound care technologies are transforming the treatment landscape. Innovative products such as advanced dressings, negative pressure wound therapy systems, and bioengineered skin substitutes are improving healing outcomes and reducing treatment time. Healthcare providers are increasingly adopting modern wound care solutions to manage complex wounds more effectively.

Looking ahead, the Global Chronic Wound Care Market is expected to grow due to increasing investments in wound management research and healthcare infrastructure. Companies are focusing on developing more efficient and cost-effective wound care products to meet the growing demand. As awareness about chronic wound management continues to rise and healthcare systems prioritize advanced treatment solutions, the market is projected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Diabetic Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Others

By Product

  • Advanced Wound Dressings
  • Wound Care Devices
  • Active Therapy
  • Others

By End User

  • Hospitals & Wound Clinics
  • Homecare Settings & Others

COMPANIES PROFILED

  • 3M Company, AdvaCare Pharma, B. Braun Melsungen AG, Baxter International Inc., Cardinal Health, Inc., Coloplast Corp., ConvaTec Group plc, Essity AB (BSN Medical), Integra LifeSciences Corporation (Derma Sciences), Johnson & Johnson, Medline Industries, Inc., MiMedx Group, Inc., Molnlycke Health Care AB, PAUL HARTMANN AG, Smith & Nephew plc, Tissue Regenix Group plc

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CHRONIC WOUND CARE MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Diabetic Ulcers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Pressure Ulcers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Venous Leg Ulcers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CHRONIC WOUND CARE MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Advanced Wound Dressings Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Wound Care Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Active Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CHRONIC WOUND CARE MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals & Wound Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Homecare Settings & Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CHRONIC WOUND CARE MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Product
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Product
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Product
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Product
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Product
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CHRONIC WOUND CARE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 3M Company
    • 9.2.2 AdvaCare Pharma
    • 9.2.3 B. Braun Melsungen AG
    • 9.2.4 Baxter International Inc
    • 9.2.5 Cardinal HealthInc
    • 9.2.6 Coloplast Corp
    • 9.2.7 ConvaTec Group Plc
    • 9.2.8 Essity AB (BSN Medical)
    • 9.2.9 Integra LifeSciences Corporation (Derma Sciences)
    • 9.2.10 Johnson & Johnson
    • 9.2.11 Medline IndustriesInc
    • 9.2.12 MiMedx GroupInc
    • 9.2.13 Molnlycke Health Care AB
    • 9.2.14 PAUL HARTMANN AG
    • 9.2.15 Smith & Nephew Plc
    • 9.2.16 Tissue Regenix Group Plc